Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model

Neurobiology of Aging

Volumn 34, Issue 8, 2013, Pages 2064-2070

  Takeda, Shuko ^a   Sato, Naoyuki ^a   Ikimura, Kazuko ^b   Nishino, Hirohito ^b   Rakugi, Hiromi ^a   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Research and Development   (Japan)

Author keywords

Alzheimer's disease; Blood brain barrier; Infection; Inflammatory cytokine; Noncognitive symptoms

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; BRAIN LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENCEPHALITIS; IN VIVO STUDY; INTERSTITIAL FLUID; MICRODIALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICE, TRANSGENIC; MOLECULAR TARGETED THERAPY;

EID: 84877586983     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.02.010     Document Type: Article

References (40)

1. Bell R.D., Winkler E.A., Singh I., Sagare A.P., Deane R., Wu Z., Holtzman D.M., Betsholtz C., Armulik A., Sallstrom J., Berk B.C., Zlokovic B.V. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012, 485:512-516.
2. Buchanan J.B., Sparkman N.L., Chen J., Johnson R.W. Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice. Psychoneuroendocrinology 2008, 33:755-765.
3. Chen J., Buchanan J.B., Sparkman N.L., Godbout J.P., Freund G.G., Johnson R.W. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav. Immun. 2008, 22:301-311.
4. Cirrito J.R., May P.C., O'Dell M.A., Taylor J.W., Parsadanian M., Cramer J.W., Audia J.E., Nissen J.S., Bales K.R., Paul S.M., DeMattos R.B., Holtzman D.M. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J. Neurosci. 2003, 23:8844-8853.
5. Citron M. Strategies for disease modification in Alzheimer's disease. Nat. Rev. Neurosci. 2004, 5:677-685.
6. Corbett A., Smith J., Creese B., Ballard C. Treatment of behavioral and psychological symptoms of Alzheimer's disease. Curr. Treat. Opt. Neurol. 2012, 14:113-125.
7. Dickstein D.L., Biron K.E., Ujiie M., Pfeifer C.G., Jeffries A.R., Jefferies W.A. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease. FASEB J. 2006, 20:426-433.
8. Erickson M.A., Banks W.A. Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis. Brain Behav. Immun. 2011, 25:1637-1648.
9. Erickson M.A., Hartvigson P.E., Morofuji Y., Owen J.B., Butterfield D.A., Banks W.A. Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J. Neuroinflammation. 2012, 9:150.
10. Godbout J.P., Chen J., Abraham J., Richwine A.F., Berg B.M., Kelley K.W., Johnson R.W. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 2005, 19:1329-1331.
11. Godbout J.P., Johnson R.W. Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. Immunol. Allergy Clin. N. Am. 2009, 29:321-337.
12. Gutierrez E.G., Banks W.A., Kastin A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 1993, 47:169-176.
13. Hayashi S., Sato N., Yamamoto A., Ikegame Y., Nakashima S., Ogihara T., Morishita R. Alzheimer disease-associated peptide, amyloid beta40, inhibits vascular regeneration with induction of endothelial autophagy. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1909-1915.
14. Hersch E.C., Falzgraf S. Management of the behavioral and psychological symptoms of dementia. Clin. Interv. Aging 2007, 2:611-621.
15. Holmes C., Butchart J. Systemic inflammation and Alzheimer's disease. Biochem. Soc. Trans. 2011, 39:898-901.
16. Kalaria R.N. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr. Rev. 2010, 68(Suppl. 2):S74-S87.
17. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends. Neurosci. 2002, 25:154-159.
18. Lv S., Song H.L., Zhou Y., Li L.X., Cui W., Wang W., Liu P. Tumour necrosis factor-alpha affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure. Liver Int. 2010, 30:1198-1210.
19. Mann G.E., Zlokovic B.V., Yudilevich D.L. Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon. Biochim. Biophys. Acta 1985, 819:241-248.
20. Pan W., Kastin A.J. Interactions of cytokines with the blood-brain barrier: implications for feeding. Curr. Pharm. Des. 2003, 9:827-831.
21. Pan W., Kastin A.J. Tumor necrosis factor and stroke: role of the blood-brain barrier. Prog. Neurobiol. 2007, 83:363-374.
22. Pan W., Yu C., Hsuchou H., Zhang Y., Kastin A.J. Neuroinflammation facilitates LIF entry into brain: role of TNF. Am. J. Physiol. Cell Physiol. 2008, 294:C1436-C1442.
23. Perry V.H. Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol. 2010, 120:277-286.
24. Sano H., Nagai Y., Miyakawa T., Shigemoto R., Yokoi M. Increased social interaction in mice deficient of the striatal medium spiny neuron-specific phosphodiesterase 10A2. J. Neurochem. 2008, 105:546-556.
25. Sato N., Takeda S., Uchio-Yamada K., Ueda H., Fujisawa T., Rakugi H., Morishita R. Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential. Curr. Aging Sci. 2011, 4:118-127.
26. Srinonprasert V., Pakdeewongse S., Assanasen J., Eiamjinnasuwat W., Sirisuwat A., Limmathuroskul D., Praditsuwan R. Risk factors for developing delirium in older patients admitted to general medical wards. J. Med. Assoc. Thai. (Chotmaihet Thangphaet) 2011, 94(Suppl. 1):S99-S104.
27. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., Ledermann B., Burki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:13287-13292.
28. Suidan G.L., McDole J.R., Chen Y., Pirko I., Johnson A.J. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One 2008, 3:e3037.
29. Takeda S., Sato N., Ikimura K., Nishino H., Rakugi H., Morishita R. Novel microdialysis method to assess neuropeptides and large molecules in free-moving mouse. Neuroscience 2011, 186:110-119.
30. Takeda S., Sato N., Rakugi H., Morishita R. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. Mol. Biosyst. 2011, 7:1822-1827.
31. Takeda S., Sato N., Takeuchi D., Kurinami H., Shinohara M., Niisato K., Kano M., Ogihara T., Rakugi H., Morishita R. Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension 2009, 54:1345-1352.
32. Takeda S., Sato N., Uchio-Yamada K., Sawada K., Kunieda T., Takeuchi D., Kurinami H., Shinohara M., Rakugi H., Morishita R. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7036-7041.
33. Threlkeld S.W., Lynch J.L., Lynch K.M., Sadowska G.B., Banks W.A., Stonestreet B.S. Ovine proinflammatory cytokines cross the murine blood-brain barrier by a common saturable transport mechanism. Neuroimmunomodulation 2010, 17:405-410.
34. van Gool W.A., van de Beek D., Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 2010, 375:773-775.
35. Winkler E.A., Sengillo J.D., Bell R.D., Wang J., Zlokovic B.V. Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability. J. Cereb. Blood. Flow. Metab. 2012, 32:1841-1852.
36. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 2011, 12:723-738.
37. Zlokovic B.V., Begley D.J., Chain-Eliash D.G. Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine). Brain Res. 1985, 336:125-132.
38. Zlokovic B.V., Hyman S., McComb J.G., Lipovac M.N., Tang G., Davson H. Kinetics of arginine-vasopressin uptake at the blood-brain barrier. Biochim. Biophys. Acta 1990, 1025:191-198.
39. Zlokovic B.V., Mackic J.B., Djuricic B., Davson H. Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain. J. Neurochem. 1989, 53:1333-1340.
40. Zlokovic B.V., Segal M.B., Begley D.J., Davson H., Rakic L. Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone. Brain Res. 1985, 358:191-199.